Crestline Management’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Crestline Management’s Portfolio FSTX Stock Details FSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell
2018 Q1	$249K	Sell
2017 Q4	$442K	Sell
2017 Q3	$1.06M	Sell
2017 Q2	$1.33M	Buy